Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

Fig. 4

Correlation of the two LowHR subtypes (n = 23) and triple negative breast cancers (TNBC; n = 14) with proliferation rate and clinical outcome. a Boxplot comparing the Ki67 proliferation rate between the three groups. b Barplot comparing the pathological complete response of the two LowHR subgroups and TNBCs. c Kaplan–Meier plot showing overall survival rates across the three groups

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us